121 related articles for article (PubMed ID: 16370387)
21. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
Wang Y; An R; Dong X; Pan S; Duan G; Sun X
Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
[TBL] [Abstract][Full Text] [Related]
22. Tumor cell metabolism: cancer's Achilles' heel.
Kroemer G; Pouyssegur J
Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
[TBL] [Abstract][Full Text] [Related]
23. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
Gollob JA; Wilhelm S; Carter C; Kelley SL
Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
[TBL] [Abstract][Full Text] [Related]
24. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
25. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
26. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
27. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
28. Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action.
Park H; Aiyar SE; Fan P; Wang J; Yue W; Okouneva T; Cox C; Jordan MA; Demers L; Cho H; Kim S; Song RX; Santen RJ
Cancer Res; 2007 Jun; 67(12):5717-26. PubMed ID: 17575138
[TBL] [Abstract][Full Text] [Related]
29. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
30. Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1.
Chow WA; Guo S; Valdes-Albini F
Anticancer Drugs; 2006 Sep; 17(8):891-903. PubMed ID: 16940799
[TBL] [Abstract][Full Text] [Related]
31. Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent.
Katsman A; Umezawa K; Bonavida B
Drug Resist Updat; 2007; 10(1-2):1-12. PubMed ID: 17306602
[TBL] [Abstract][Full Text] [Related]
32. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
33. Turning cell cycle controller genes into cancer drugs. A role for an antiproliferative cytokine (betaGBP).
Mallucci L; Wells V; Danikas A; Davies D
Biochem Pharmacol; 2003 Oct; 66(8):1563-9. PubMed ID: 14555235
[TBL] [Abstract][Full Text] [Related]
34. Targeting senescence pathways to reverse drug resistance in cancer.
Rebbaa A
Cancer Lett; 2005 Feb; 219(1):1-13. PubMed ID: 15694659
[TBL] [Abstract][Full Text] [Related]
35. Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis.
Rabinovich GA; Cumashi A; Bianco GA; Ciavardelli D; Iurisci I; D'Egidio M; Piccolo E; Tinari N; Nifantiev N; Iacobelli S
Glycobiology; 2006 Mar; 16(3):210-20. PubMed ID: 16282605
[TBL] [Abstract][Full Text] [Related]
36. Circumventing multidrug resistance in cancer by beta-galactoside binding protein, an antiproliferative cytokine.
Ravatn R; Wells V; Nelson L; Vettori D; Mallucci L; Chin KV
Cancer Res; 2005 Mar; 65(5):1631-4. PubMed ID: 15753355
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis as the predominant tumor cell response to chemotherapy and irradiation: a case of TUNEL vision?
Gewirtz DA; Elmore LW
Curr Opin Investig Drugs; 2005 Dec; 6(12):1199. PubMed ID: 16370385
[No Abstract] [Full Text] [Related]
38. [The inhibition of apoptosis in cancer cells resistant to anticancer drugs].
Nowak R; Tarasiuk J
Postepy Biochem; 2004; 50(4):330-43. PubMed ID: 15957528
[No Abstract] [Full Text] [Related]
39. Focus issue: Rendering resistance futile.
Adler EM; Gough NR
Sci Signal; 2011 Mar; 4(166):eg3. PubMed ID: 21447795
[TBL] [Abstract][Full Text] [Related]
40. [Value of inhibition of signal transduction and epigenetic therapy concepts in cancer therapy].
Tabernero J; Kaye S
Onkologie; 2005 Oct; 28 Suppl 4():43-7. PubMed ID: 16285040
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
